GlassScriptPhysician profile
Matthew B Vance
NPI 1972504249
$2,797.79
in general payments reported to CMS, 2019-2025
26 companies · $615 in 2025
The $615 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2020: $30.43 · 2021: $67.65 · 2022: $323 · 2023: $371 · 2024: $1,149 · 2025: $615.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,133.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $656.18 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Spinefrontier, INC. | $548.09 | 2024 | Inspan |
| Abbott Laboratories | $352.25 | 2023-2025 | Eterna, Proclaim |
| Tersera Therapeutics LLC | $199.66 | 2022-2025 | Prialt |
| Nevro Corp. | $180.51 | 2019-2023 | Senza |
| Spr Therapeutics, INC | $97.35 | 2022-2025 | Sprint Pns System |
| Medtronic, INC. | $88.97 | 2022-2025 | Synchromedii |
| Pacira Pharmaceuticals Incorporated | $88.43 | 2022-2023 | Iovera |
| Nalu Medical, INC. | $85.87 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $59.35 | 2024-2025 | |
| Painteq LLC | $42.82 | 2022-2023 | Painteq |
| Actelion Pharmaceuticals US, INC. | $40.49 | 2024 | Uptravi, Opsumit |
| Stimwave Technologies Incorporated | $40.03 | 2019-2020 | |
| Convatec INC. | $39.91 | 2024-2025 | |
| Pfizer INC. | $36.11 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $35.68 | 2019 | |
| Averitas Pharma INC. | $28.95 | 2025 | Qutenza |
| Avanos Medical | $26.39 | 2023 | Coolief* Cooled Radiofrequency |
| Globus Medical, INC. | $24.46 | 2025 | Senza |
| Biohaven Pharmaceutical Holding Company LTD. | $21.92 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $21.90 | 2023 | Seglentis |
| Relievant Medsystems, INC. | $19.84 | 2022 | |
| Amgen INC. | $19.17 | 2023 | Prolia, Evenity |
| Octapharma USA, INC. | $16.21 | 2025 | Fibryga |
| Bioventus LLC | $14.44 | 2022 | |
| Merit Medical Systems INC | $12.81 | 2023 | Stabilit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Vance listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.